Dr. William Grady is the Rodger C. Haggitt Professor of Medicine, Gastroenterology Division, University of Washington School of Medicine and Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center. He is also the Co-Head of the GI Cancer Program of the Fred Hutchinson Cancer Center (FHCC)/University of Washington Comprehensive Cancer Center and Medical Director of the GI Cancer Prevention Program Clinic at the Fred Hutchinson Cancer Center. Dr. Grady is a cellular and molecular biologist and board-certified gastroenterologist. He is the contact PI of a multi-PI Early Detection Research Network (NCI) Biomarker Characterization Center; OncoAging Consortium Center and of a Translational Biology of Early Lesions (TBEL) Center.  His NCI funded projects assess the role of epigenetic alterations as risk markers and biomarkers for esophageal and colon cancer, respectively and of the role of genetic and epigenetic alterations in carcinogenesis.